Payers remain challenged by CMS' interoperability and prior auth rule

Neil Patel, head of ventures at Redesign Health, discusses the current digital health landscape, how investment has evolved since the COVID-19 pandemic and what investors look for when evaluating the next generation of healthcare companies.

New artificial intelligence models have unpredictable consumption-based costs, says Rhett Alden, Elsevier's CTO of health markets. But "all you can eat models" and inclusive pricing can avoid the need for clinicians to meter tool use.

The underlying challenge is how to fund an industry that's very important but is also perpetually on the brink of bankruptcy, says Kunal Sarda, CEO of Arya Health.